Verve Therapeutics
VERV
#5968
Rank
A$1.41 B
Marketcap
A$15.80
Share price
0.00%
Change (1 day)
100.09%
Change (1 year)

Verve Therapeutics (VERV) - Total debt

Total debt on the balance sheet as of March 2025 : A$97.41 Million

According to Verve Therapeutics's latest financial reports the company's total debt is A$97.41 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Verve Therapeutics - Total debt on balance sheet (from 2020 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$0.11 B2.33%
2023-12-31A$0.10 B-8.67%
2022-12-31A$0.12 B4364.04%
2021-12-31A$2.69 M
2020-12-31N/A